The emerging genetic diversity of HIV: The importance of global surveillance for diagnostics, research, and prevention

JAMA

Volumn 275, Issue 3, 1996, Pages 210-216

  Hu, Dale J ^a   Dondero, Timothy J ^a   Rayfield, Mark A ^b   George, J Richard ^b,c,d   Schochetman, Gerald ^b   Jaffe, Harold W ^b   Luo, Chi Cheng ^b   Kalish, Marcia L ^b   Weniger, Bruce G ^a   Pau, Chou Pong ^b   Schable, Charles A ^b   Curran, James W ^a,e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c Epitope Inc   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

COST EFFECTIVENESS ANALYSIS; GENE MUTATION; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RESEARCH; REVIEW; SCREENING TEST; VIRUS RESISTANCE; VIRUS TRANSMISSION; VIRUS TYPING;

EID: 13344278708     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.3.210     Document Type: Review

References (119)

1. Lederberg J, Shope RE, Oaks SC Jr, eds. Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy of Sciences; 1992.
2. Centers for Disease Control. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. MMWR Morb Mortal Wkly Rep. 1981;30:305-308.
3. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS), Science. 1983;220:868-871.
4. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984;224:497-500.
5. Loussert-Ajaka I, Ly TD, Chaix ML, et al. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet. 1994;343:1393-1394.
6. Schable C, Zekeng L, Pau CP, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet. 1994;344:1333-1334.
7. Centers for Disease Control and Prevention. Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States. Atlanta, Ga: US Dept of Health and Human Services, Public Health Service; 1994.
8. Clavel F, Guetard D, Brun-Vezinet F, et al. Isolation of a new retrovirus from West African patients with AIDS. Science. 1986;233:343-346.
9. De Cock KM, Adjorlolo G, Ekpini E, et al. Epidemiology and transmission of HIV-2 - why there is no HIV-2 pandemic. JAMA. 1993;270:2083-2086.
10. Nzilambi N, De Cock KM, Forthal DN, et al. The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. N Engl J Med. 1988;318:276-279.
11. Chakrabarti L, Guyader M, Alizon M, et al. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature. 1987;328:543-547.
12. Peeters M, Honore C, Huet T, et al. Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS. 1989;3:625-630.
13. Doolittle RF. The simian-human connection. Nature. 1989;339:338-339.
14. Quinn TC. Population migration and the spread of types 1 and 2 human immunodeficiency viruses. Proc Natl Acad Sci U S A. 1994;91:2407-2414.
15. Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S. Rapid evolution of RNA genomes. Science. 1982;215:1577-1585.
16. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995;373:123-126.
17. Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993;259:1749-1754.
18. Hahn BH, Shaw GM, Taylor ME, et al. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science. 1986;232: 1548-1553.
19. Sakai K, Dewhurst S, Ma X, Volsky DJ. Differences in cytopathogenicity and host cell range among infectious molecular clones in human immunodeficiency virus type 1 simultaneously isolated from an individual. J Virol. 1988;62:4078-4085.
20. Shpaer EG, Mullins JI. Rates of amino acid change in the envelope protein correlate with pathogenicity of primate lentiviruses. J Mol Evol. 1993; 37:57-65.
21. Kliks SC, Shioda T, Haigwood NL, Levy JA. VS variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1993;90:11518-11522.
22. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406-425.
23. Felsenstein J. Phylogenies from molecular sequences: inference and reliability. Annu Rev Genet. 1988;22:521-565.
24. Li WH. A statistical test of phylogenies estimated from sequence data. Mol Biol Evol. 1989;6:424-435.
25. Hillis DM, Huelsenbeck JP, Cunningham CW. Application and accuracy of molecular phylogenies. Science. 1994;264:671-677.
26. Louwagie J, McCutchan FE, Peeters M, et al. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS. 1993;7:769-780.
27. Myers G, Korber B, Wain-Hobson S, Jeang KT, Henderson LE, Pavlakis GN, eds. Human Retroviruses and AIDS 1994. Los Alamos, NM: Los Alamos National Laboratory; 1994. Entries are regularly updated and available through electronic mail on the Internet.
28. Kostrikis LG, Bagdades E, Cao Y, Zhang L, Dimitriou D, Ho DD. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I. J Virol 1995;69:6122-6130.
29. DeLeys R, Vanderborght B, Vanden Haesevelde M, et al. Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. J Virol. 1990;64:1207-1216.
30. Gurtler LG, Hauser PH, Eberle J, et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol. 1994;68:1581-1585.
31. Gao F, Yue L, Robertson DL, et al. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol. 1994;68:7433-7447.
32. Sharp PM, Robertson DL, Gao F, Hahn BH. Origins and diversity of human immunodeficiency viruses. AIDS. 1994;8(suppl 1):S27-S42.
33. Artenstein AW, Coppola J, Brown AE, et al. Multiple introductions of HIV-1 subtype E into the western hemisphere. Lancet. 1995;346:1197-1198.
34. Bobkov A, Cheingsong-Popov R, Garaev M, et al. Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus. AIDS. 1994;3:1649-1655.
35. Lukashov W, Cornelissen MTE, Goudsmit J, et al. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania. AIDS. 1995;9:435-439.
36. Dumitrescu O, Kalish ML, Kliks SC, Bandea CI, Levy JA. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. J Infect Dis. 1994;169:281-288.
37. Weniger BG, Takebe Y, Ou CY, Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS. 1994;8(suppl 2):S13-S28.
38. Williamson C, Engelbrecht S, Lambrick M, et al. HIV-1 subtypes in different risk groups in South Africa. Lancet. 1995;346:782.
39. Tsuchie H, Saraswathy TS, Sinniah M, et al. HIV-1 variants in South and South-East Asia. Int J STD AIDS. 1995;6:117-120.
40. Luo CC, Tian C, Hu DJ, et al. HIV-1 subtype C in China. Lancet. 1995;345:1051-1052.
41. Rubsamen-Waigmann H, Von Briesen H, Holmes H, et al. Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. AIDS Res Hum Retroviruses. 1994;10:1401-1408.
42. Artenstein AW, VanCott TC, Mascola JR, et al. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis. 1995;171:805-810.
43. Pieniazek D, Janini LM, Ramos A, et al. HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic. Emerging Infect Dis. 1995; 1:86-88.
44. Hu WS, Temin HM. Retroviral recombination and reverse transcription. Science. 1990;250:1227-1233.
45. Li WH, Tanimura M, Sharp PM. Rates and dates of divergence between AIDS virus nucleotide sequences. Mol Bol Evol. 1988;5:313-330.
46. Sabino EC, Shpaer EG, Morgado MG, et al. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol. 1994;68:6340-6346.
47. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination of HIV-1. Nature. 1995;374:124-126.
48. O'Brien TR, Polon C, Schable CA, et al. HIV-2 infection in an American. AIDS. 1991;5:85-88.
49. Centers for Disease Control and Prevention. Update: HIV-2 infection among blood and plasma donors - United States, June 1992-June 1995. MMWR Morb Mortal Wkly Rep. 1995;44:603-606.
50. Gao F, Yue L, Hill SC, et al. HIV-1 sequence subtype D in the United States. AIDS Res Hum Retroviruses. 1994;10:625-627.
51. Brodine SK, Mascola JR, Weiss PJ, et al Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 1995;346:1198-1199.
52. WHO Network for HIV Isolation and Characterization. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses. 1994;10:1327-1343.
53. Ou CY, Takebe Y, Luo C, et al Wide distribution of two subtypes of HIV-1 in Thailand. AIDS Res Hum Retroviruses. 1992;8:1887-1895.
54. Ou CY, Takebe Y, Weniger BG, et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet. 1993;341:1171-1174.
55. Pau CP, Lee-Thomas S, Auwanit W, et al. Highly specific V3 peptide enzyme immunoassay for serotyping HIV type 1 specimens from Thailand. AIDS. 1993;7:337-340.
56. Kalish ML, Luo CC, Weniger BG, et al. Early HIV type 1 strains in Thailand were not responsible for the current epidemic. AIDS Res Hum Retroviruses. 1994;10:1573-1575.
57. Pfutzner A, Dietrich U, von Eichel U, et al. HIV-1 and HIV-2 infections in a high-risk population in Bombay, India: evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype. J Acquir Immune Defic Syndr. 1992;5:972-977.
58. Louwagie J, Delwart EL, Mullins JI, McCutchan FE, Eddy G, Burke DS. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses. 1994;5:561-567.
59. Nkengasong JN, Peeters M, vanden Haesevelde M, et al. Antigenic evidence of the aberrant HIV-1 ANT70 virus in Cameroon and Gabon. AIDS. 1993; 7:1536-1538.
60. Zekeng L, Gurtler L, Afane Ze E, et al. Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results. AIDS. 1994;8:1626-1628.
61. Dondero TJ, Hu DJ, George JR. HIV-1 variants: yet another challenge to public health. Lancet. 1994;343:1376.
62. Schochetman G, George JR, eds. AIDS Testing: A Comprehensive Guide to Technical, Medical, Social, Legal, and Management Issues. 2nd ed. New York, NY: Springer-Verlag NY Inc; 1994.
63. Pau CP, Kai M, Holloman-Candal DL, et al. Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. AIDS Res Hum Retroviruses. 1994;10:1369-1377.
64. Cheingsong-Popov R, Lister S, Callow D, et al. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. AIDS Res Hum Retroviruses. 1994;10:1379-1386.
65. Delaporte E, Dupont A, Merlin M, et al. Seroepidemiological survey of HIV-1 and HIV-2 antibodies in Gabon. AIDS. 1988;2:136-137.
66. Smith JD, Brace CB, Featherstone ASR, et al. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses. 1994;10:577-583.
67. Ou CY, Kwok S, Mitchell SW, et al. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science. 1988; 239:295-297.
68. Ou CY, McDonough SH, Cabanas D, et al. Rapid and quantitative detection of enzymatically amplified HIV-1 DNA using chemiluminescent oligonucleotide probes. AIDS Res Hum Retroviruses. 1990;6:1323-1329.
69. Delwart EL, Shpaer EG, Louwagie J, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 1993;262:1257-1261.
70. Holmes EC, Zhang LQ, Robertson P, et al. The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis. 1995; 171:45-53.
71. Kuiken CL, Zwart G, Baan E, et al Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc Natl Acad Sci U S A. 1993;90:9061-9065.
72. Bobkov A, Garaev MM, Rzhaninova A, et al. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data. AIDS. 1994;8:619-624.
73. Louwagie J, McCutchan F, van der Groen G, et al. Genetic comparison of HIV-1 isolates from Africa, Europe, and North America. AIDS Res Hum Retroviruses. 1992;8:1467-1469.
74. Korber B, Myers G. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses. 1992;8:1549-1560.
75. Centers for Disease Control. Possible transmission of human immunodeficiency virus to a patient during an invasive dental procedure. MMWR Morb Mortal Wkly Rep. 1990;39:489-493.
76. Ou CY, Ciesielski C, Myers G, et al. Molecular epidemiology of HIV transmission in a dental practice. Science. 1992;256:1165-1171.
77. Centers for Disease Control and Prevention. Update: investigations of persons treated by HIV-infected health-care workers - United States. MMWR Morb Mortal Wkly Rep. 1993;42:329-337.
78. Fitzgibbon JE, Gaur S, Frenkel LD, Laraque F, Edlin BR, Dubin DT. Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med. 1993;329:1835-1841.
79. Centers for Disease Control and Prevention. HIV transmission between two adolescent brothers with hemophilia. MMWR Morb Mortal Wkly Rep. 1993;42:948-951.
80. Chant K, Lowe D, Rubin G, et al. Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet. 1993;342:1548-1549.
81. Jaffe HW, McCurdy JM, Kalish ML, et al. Lack of HIV transmission in the practice of a dentist with AIDS. Ann Intern Med. 1994;121:855-859.
82. Andreasson PA, Dias F, Naucler A, Anderson S, Biberfeld GA. Prospective study of vertical transmission of HIV-2 in Bissau, Guinea Bissau. AIDS. 1993;7:989-993.
83. The HIV Infection in Newborns French Collaborative Study Group. Comparison of vertical human immunodeficiency virus type 2 and human immunodeficiency virus type 1 transmission in the French prospective cohort. Pediatr Infect Dis J. 1994;13:502-506.
84. Adjorlolo-Johnson G, De Cock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA. 1994;272:462-466.
85. Kanki PJ, Travers KU, MBoup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet. 1994;343:943-946.
86. Wolinsky SM, Wike CM, Korber BTM, et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science. 1992;255:1134-1137.
87. Wike CM, Korber BTM, Daniels MR, et al. HIV-1 sequence variation between isolates from mother-infant transmission pairs. AIDS Res Hum Retroviruses. 1992;8:1297-1300.
88. Kunanusont C, Foy HM, Kreiss JK, et al. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet. 1995;345:1078-1083.
89. Essex M. Lessons learned from HIV molecular biology. Presented at the Third International Conference on AIDS in Asia and the Pacific; September 19, 1995; Chiang Mai, Thailand.
90. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. 1993;328:327-335.
91. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen ISY. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science. 1987;236:819-822.
92. Fenyö EM, Morfeldt-Mansson L, Chiodi F, et al. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988;62:4414-4419.
93. Cloyd MW, Moore BE. Spectrum of biologic properties of human immunodeficiency virus (HIV-1) isolates. Virology. 1990;174:103-116.
94. Westervelt P, Trowbridge DB, Epstein LG, et al. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol. 1992; 66:2577-2582.
95. Korber BTM, Kunstman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol. 1994;68:7467-7481.
96. Cheng-Mayer C, Seto D, Tateno M, Levy JA. Biologic features of HIV-1 that correlate with virulence in the host. Science. 1988;240:80-82.
97. Schuitemaker H, Koot M, Kootstra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol. 1992;66:1354-1360.
98. - T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infeeted individuals. J Virol 1993;67:1772-1777.
99. Richman DD, Bozzette SA. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis. 1994;169:968-974.
100. Learmont J, Tindall B, Evans L, et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet. 1992; 340:863-867.
101. Ashton LJ, Learmont J, Luo K, Wylie B, Stewart G, Kaldor JM. HIV infection in recipients of blood products from donors with known duration of infection. Lancet. 1994;344:7:8-720.
102. De Wolf F, Hogervorst E. Goudsmit J, et al. Syncytium-inducing and non-syncytium-inducing capacities of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res Hum Retroviruses 1994; 10:1387-1400.
103. Zhong P, Peeters M, Janssens W, et al. Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses. 1995;11:239-248.
104. De Cock KM, Odehouri K, Colebunder RL, et al. A comparison of HIV-1 and HIV-2 infections in hospitalized patients in Abidjan, Côte d'Ivoire. AIDS. 1990;4:443-448.
105. Le Guenno BM, Barabe P, Griffet PA, et al. HIV-2 and HIV-1 AIDS cases in Senegal: clinical patterns and immunological perturbations. J Acquir Immune Defic Syndr. 1991;4:421-427.
106. Pepin J, Morgan G, Dunn D, et al. HIV-2 induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS. 1991;5:1165-1172.
107. Kesten L, Brattegaart K, Adjorlolo G, et al. Immunological comparison of HIV-1, HIV-2 and dually-reactive women delivering in Abidjan, Côte d'Ivoire. AIDS. 1992;6:803-807.
108. Whittle H, Morris J, Todd J, et al. HIV-2-infected patients survive longer than HTV-1-infected patients. AIDS. 1994;8:1617-1620.
109. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994;265:1587-1590.
110. Weniger BG, Tansuphaswadikul S, Young NL, et al. Differences in immune function among patients infected with distinct Thailand HIV-1 strains. Presented at the Tenth International Conference on AIDS; August 8, 1994; Yokohama, Japan. Abstract 012C.
111. Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 1989;243:1731-1734.
112. Larder BA, Kemp SD. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science. 1989;246:1155-1158.
113. Loveday C, Kaye S, Tenant-Flowers M, et al. HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy, Lancet 1995; 345:820-824.
114. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995;373:117-122.
115. Mohri H, Singh MK, Ching WT, Ho DD. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and uncreated patients. Proc Natl Acad Sci USA. 1993; 90:25-29.
116. Erice A, Mayers DL, Strike DG, et al. Primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med. 1993;328:1163-1165.
117. Siegrist CA, Yerly S, Kaiser L, Wyler CA, Perrin L. Mother to child transmission of zidovudineresistant HIV-1. Lancet. 1994;344:1771-1772.
118. Lurie P, Bishaw M, Chesney MA, et al. Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. JAMA. 1994;271:295-301.
119. Heneine W, Yamamoto S, Switzer WM, Spira TJ, Folks TM. Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type 1. J Infect Dis. 1995;171:1210-1216.